Elicera Therapeutics

The grant is awarded to Professor Magnus Essand in his role as an employed academic researcher at Uppsala University and forms a natural part of the academic research activities. The funding, which spans three years, enables continued work for Essand's research group in the CAR T-cell field. With annual funding of 2.5 MSEK - an increase from the previous 1.75 MSEK - the group can now allocate greater resources to the research than before.